research Global Epidemiology of Telogen Effluvium After COVID-19 Pandemic: A Systematic Review and Modeling Study
Telogen effluvium increased globally after COVID-19, especially in Asian and Latin regions.
Search
for
Sort by
Research
360-390 / 1000+ results 
research Impact of the COVID-19 Pandemic on Telogen Effluvium: A Nationwide Multicentre Interrupted Time Series Study
COVID-19 increased hair loss cases, but vaccination did not.
research Dermatologic Implications of COVID-19 Infection and Immunization: Hair Loss
Early treatment of COVID-19-related hair loss is crucial for better outcomes.
research COVID-19 and Autoimmunity in Dermatology: A Moroccan Case Series and Literature Review
COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.
research Efficacy of Dr. SKS Hair Booster Serum for the Treatment of Hair Loss in COVID-19 Induced Persistent Telogen Effluvium
Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.
research COVID-19-Associated Telogen Effluvium After Hospital Discharge: A Prospective Cohort Study
Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.
research Capillary Impacts of Covid-19: The Link Between Acute Telogen Effluvium and Alopecia Areata - An Integrative Review
Covid-19 can cause hair loss due to immune and psychological factors.
research A Case of Chronic Kidney Disease Patient With Rapid Deterioration of Renal Function, Hair Loss, and Spontaneous Resolution of Facial Warts After COVID-19 Infection
A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.
research Characteristics of Hair Loss in COVID-19 Patients in Thailand
COVID-19 patients in Thailand typically started losing hair about 30 days after infection, with women experiencing more severe hair loss.
research COVID-19-Induced Hair Shedding and Related Risk Factors: A Saudi Perspective
Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.
research A Cross-Sectional Study on Post-Coronavirus Disease Hair Loss at a Tertiary Care Hospital
Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.
research The Effect of Ferritin, Vitamin D, and Hormonal and Biochemical Parameters on Female-Pattern Hair Loss After COVID-19 Infection
Low ferritin and Vitamin D levels may cause hair loss after COVID-19.
research Telogen Effluvium: A Post-COVID-19 Sequela
COVID-19 may cause a common type of hair loss called telogen effluvium.
research Alopecia: An Overall Review Including Causes, COVID-19, Diet, and Treatments
The document concludes that alopecia is an incurable autoimmune disease with various treatments and that diet, as well as COVID-19, may impact it.
research Proposal for Clinical Classification of Cutaneous Manifestations in COVID-19 and Post-Vaccination Against SARS-CoV-2: An Observational Study
Most skin issues were due to COVID-19, with some caused by vaccines or treatments, and were categorized into five types.
research Telogen Effluvium and COVID-19: A Cross-Sectional Study
COVID-19 infection is highly related to increased hair loss, especially in women.
research Impact of Stem Cell-Based Therapy and Platelet-Rich Plasma in Hair Loss and Telogen Effluvium Related to COVID-19
Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.
research The Effectiveness of Microneedling in the Treatment of Post-COVID-19 Hair Disorders
Microneedling therapy is effective and safe for treating hair disorders worsened by COVID-19.
research Evaluation of the Relationship Between Favipiravir Use and Telogen Effluvium in COVID-19 Patients
Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.
research Hormone Replacement Therapy and COVID-19 Outcomes in Solid Organ Transplant Recipients Compared With the General Population
Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.
research Severe COVID-19 Infection Predisposes Patients to Greater Burden of Hair Loss
People who had severe COVID-19 are more likely to experience hair loss.
research Alopecia Areata as a Sequela of Post-Reinfection COVID-19
COVID-19 reinfection may trigger alopecia areata.
research Effect of Age and Gender on Alopecia in Patients Hospitalized with COVID-19
Older male COVID-19 patients are more likely to experience hair loss.
research The Association of Hair Loss and Coronavirus Infection COVID-19 – Facts and Hypotheses
COVID-19 may cause different types of hair loss, and the virus's effects on hair could help understand its impact on other body parts.
research Sudden Hair Loss and COVID-19
Sudden hair loss might be a symptom of COVID-19.
research A Prospective Cross-Sectional Study on Post COVID-19 Hair Loss at a Tertiary Care Hospital
Many patients experienced severe hair loss after COVID-19, especially older adults and women.
research Self-Reported Hair Loss Following COVID-19: An Observational Study
Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.
research Prevalence Of Telogen Effluvium In Egyptian Women With Post-Covid 19 Viral Infection
Many Egyptian women who were hospitalized for COVID-19 experienced significant hair loss afterwards.
research Alopecia and COVID-19: Possible Etiopathogenetic Variants and Therapeutic Approach
COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.
research Hair Loss and Androgen's Role in the Era of COVID-19
Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.